BRCA-related ovarian carcinoma : Another piece of the puzzle?
β Scribed by Stephen C. Rubin
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 44 KB
- Volume
- 97
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
The author comments on a report in this issue of Cancer by investigators who used clinical response endpoints and chemoresistance testing to confirm the improved survival of women with hereditary ovarian carcinoma compared with women who had sporadic ovarian carcinoma. The possible use of BRCA mutation status to improve patient care, the future of translational research, and the difficulties in proceeding with largeβscale prospective trials are among the topics discussed.
See also pages 2187β95.
π SIMILAR VOLUMES
disease and, in fact, all RIBA-positive patients had abnormal liver histological results. As yet unanswered is the question of whether histological liver disease in the absence of biochemical abnormalities suggestive of hepatic inflammation can progress to more advanced liver disease, including cir
onalcoholic fatty liver disease (NAFLD) is associated with insulin resistance and is considered the hepatic expression of the metabolic syndrome. Subjects with features of the metabolic syndrome are at risk of developing cardiovascular disease and coronary heart disease (CHD), 1 and recent evidence